✦ LIBER ✦

Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?

✍ Scribed by Kathy D Miller

Book ID: 120700390
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 58 KB
Volume: 6
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr782

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ad5CMVp53 gene therapy for locally advan

Ad5CMVp53 gene therapy for locally advanced prostate cancer – where do we stand?

✍ Paul Sweeney; Louis L. Pisters 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 182 KB

Nonmastectomy Therapy for Breast Cancer:

Nonmastectomy Therapy for Breast Cancer: Where Do We Go From Here?

✍ Lichter, Allen S. 📂 Article 📅 1994 🏛 Mayo Clinic 🌐 English ⚖ 276 KB

Environmental pollutants, diet, physical

Environmental pollutants, diet, physical activity, body size, and breast cancer : Where do we stand in research to identify opportunities for prevention?

✍ Julia Green Brody; Ruthann A. Rudel; Karin B. Michels; Kirsten B. Moysich; Lesli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Breast cancer is the most common invasive cancer in women worldwide and the leading cause of death in US women in mid-life. Treatment has adverse effects, adding to the importance of finding modifiable risk factors. At the invitation of Susan G. Komen for the Cure, we reviewed studies of breast canc

Bone-targeted therapy for metastatic bre

Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting

✍ Zhu, Xiaofu; Amir, Eitan; Singh, Gurmit; Clemons, Mark; Addison, Christina 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 266 KB